Introduction: Pharmacogenomics (PGx), an essential component of Personalized Medicine (PM), holds the potential to transform modern medical practice. While significant efforts have been made to ...
We performed a single-institution, retrospective analysis of CGP utilization and treatment patterns in patients with localized PDAC who underwent curative-intent resection in the contemporary period ...
CEO Yu-Hsin Lin highlighted the completion of Phase III PHOENIX trial enrollment with 530 subjects for geographic atrophy and the completion of the Phase III DRAGON trial for Stargardt's disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results